Dyno Nobel (DNL) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
8 Jun, 2026Executive summary
Statutory after-tax profit of $7 million for 1H25, reversing a $148 million loss in 1H24, with underlying NPAT ex IMIs at $88 million compared to $164 million in 1H24.
Transformation program delivered $25 million EBIT uplift in 1H25, with total transformation benefits at $89 million to date and targeting a 40–50% EBIT exit run rate for FY25.
Major progress on fertilizer business separation, with sale agreements for Distribution, Perdaman Offtake, and Gibson Island land, expected to deliver up to $835 million in gross proceeds.
Major turnarounds at Moranbah and LOMO completed safely, on time, and on budget.
Safety performance improved, with TRIFR reduced to 1.03 from 1.101 year-over-year.
Financial highlights
Group revenue for 1H25 was $2,251 million, down 9% year-over-year, primarily due to asset sales and lower demand in coal and fertilizers.
EBIT ex IMIs was $174 million (1H24: $249 million); EBITDA ex IMIs was $323 million (1H24: $425 million).
NPAT ex IMIs was $88 million, down from $164 million in 1H24; statutory NPAT including IMIs was $7 million.
Interim dividend of 2.4 cents per share (unfranked), representing a 51% payout ratio.
Net debt/EBITDA increased to 1.6x, expected to return below 1.5x by year-end.
Outlook and guidance
Transformation program expected to deliver a 40–50% EBIT uplift by FY25 exit, with full-year turnaround impact guided at $45–55 million.
Second half earnings expected to be stronger as deferred fertilizer sales are recovered and turnaround impacts subside.
Fertilizer earnings expected to be heavily second-half weighted, with full-year EBIT in the $40–60 million range.
Net interest expense for FY25 forecast at $125–130 million; effective tax rate expected between 20–25%.
Gas supply costs at Phosphate Hill expected to be $40–80 million above contract pricing in FY25.
Latest events from Dyno Nobel
- Record underlying EBIT growth and transformation progress, despite statutory net loss from impairments.DNL
H2 20248 Jun 2026 - FY25 EBIT ex IMIs up 23%, $579m asset sale cash, $1.4bn capital return, FY26 EBIT $460m–$500m.DNL
H2 20258 Jun 2026 - EBIT up 39% and NPAT ex IMIs up 83% YoY; FY26 EBIT guidance and buyback progress reaffirmed.DNL
H1 20268 Jun 2026 - Strong financial results, strategic transformation, and robust shareholder support defined the AGM.DNL
AGM 20253 Feb 2026 - Doubling EBIT in 3–4 years, tech-driven growth, and strong capital returns targeted.DNL
Investor Showcase 20243 Feb 2026 - Fertilizer sale talks end; AUD 900m buyback begins, with FY24 outlook steady.DNL
Investor Update3 Feb 2026